Developer docs
API playgroundTry for free, no card

Search company profiles

NeuroLogica

Full company profile

uuid00073b1

Namestring
NeuroLogica
Legal namestring
Samsung Healthcare
Websiteurl
neurologica.com
Company typeenum
Private
Founded yearint
2004
Descriptiontext

NeuroLogica designs, engineers, manufactures, and markets mobile computed tomography (CT) imaging equipment for healthcare facilities and private practices, with a specific focus on point-of-care imaging that eliminates the need to transport critically ill patients to fixed radiology suites. The company was founded in 2004 and is headquartered in Danvers, Massachusetts, operating as a wholly-owned subsidiary of Samsung Medison (the medical imaging arm of Samsung Electronics); in March 2026, Samsung Medison unified NeuroLogica with Boston Imaging under the corporate identity Samsung HME (Healthcare and Medical Equipment) America, consolidating ultrasound, digital radiography, and CT operations under a single U.S. structure aligned with the global Samsung brand.

The product portfolio is built around four core mobile CT systems: the BodyTom 64 for full-body imaging in adult and pediatric ICUs, interventional radiology, and surgery; the CereTom Elite for compact, rapid brain and neck imaging in neuro and critical care; the OmniTom Elite for advanced neuro, head, and neck imaging; and the OmniTom Elite with PCD, which integrates photon-counting detector technology for ultra-detailed imaging in advanced neuro and research applications. The underlying technology platform emphasizes miniaturization of the CT form factor and, per company materials, incorporates AI-driven imaging capabilities to enhance diagnostic quality at the bedside. The company is also developing next-generation photon-counting detector technology as a roadmap asset.

NeuroLogica generates revenue through one-time capital equipment sales of mobile CT scanners to enterprise healthcare buyers, with pricing handled via quote-based procurement rather than disclosed list prices. Distribution is conducted through Samsung Healthcare's direct enterprise field sales organization globally, with regional expansion supported by partnerships such as the August 2025 Samsung India agreement covering the Indian market. Customer use cases span hospital ICUs and critical care (the primary segment), neurology and neurocritical care, pediatric healthcare, surgery and interventional radiology, and emergency medical services including mobile stroke units. The company maintains 51-100 employees and markets through Samsung Healthcare's integrated digital channels, industry events, and regional sales coverage.

Short descriptiontext

NeuroLogica, a Samsung Medison subsidiary now operating under Samsung HME America, designs and manufactures mobile computed tomography (CT) scanners for hospitals and healthcare facilities, enabling point-of-care imaging in ICUs, operating rooms, neurology, pediatrics, and emergency stroke settings.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersDanvers, United States
HQ citystring
Danvers
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
mobile CT scanners, medical imaging equipment, computed tomography systems, point-of-care imaging, radiology hardware
Industry3 codes
1Computed Tomography (CT) Systems
CodeHLAHABABPrimaryYes
2Portable, Mobile & Point-of-Care Imaging Systems
CodeHLAHABALPrimaryNo
3Interventional Radiology & Image-Guided Therapy Systems
CodeHLAHABAGPrimaryNo
NAICS code3 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
  • Medical Equipment and Supplies Manufacturing3391
SIC code2 codes
  • X-Ray Apparatus & Tubes & Related Irradiation Apparatus3844
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Imaging Equipment
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Mobile CT Scanner Hardware Sales
TypeHardware Sales
Description

Sale of mobile CT scanner systems including BodyTom, CereTom, and OmniTom product lines. Hardware is sold as one-time capital equipment purchases to healthcare facilities.

usa.samsunghealthcare.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Marketing or Sales, Personnel, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1NeuroLogica
Description

Mobile CT scanner product line featuring BodyTom, CereTom Elite, OmniTom Elite, and OmniTom Elite PCD systems for point-of-care imaging

usa.samsunghealthcare.com
Core offering1 text field

NeuroLogica designs, engineers, manufactures and markets mobile computed tomography (CT) scanner systems that bring point-of-care imaging to hospital ICUs, operating rooms, interventional radiology suites, and emergency/mobile stroke settings. Its product line includes the BodyTom 64 (full-body mobile CT), CereTom Elite (compact brain/neck CT), OmniTom Elite (advanced neuro/head/neck CT), and OmniTom Elite with PCD (photon-counting detector CT) for research-grade imaging.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

NeuroLogica, operating under Samsung HME (Healthcare and Medical Equipment) America, provides a portfolio of mobile computed tomography (CT) scanner solutions designed to transform fixed imaging technologies into point-of-care platforms. The product lineup includes the BodyTom 64 for full-body imaging in ICU and surgical environments, the CereTom Elite for compact brain and neck imaging, the OmniTom Elite for advanced neuro and head/neck applications, and the OmniTom Elite with PCD (photon-counting detector) for ultra-detailed research applications. Together, these mobile CT systems enable bedside diagnostics and reduce patient transfers across hospital settings.

Product and service4 records
1BodyTom 64
CategoryMobile CT Scanner
2CereTom Elite
CategoryMobile CT Scanner
3OmniTom Elite
CategoryMobile CT Scanner
4OmniTom Elite with PCD
CategoryMobile CT Scanner
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-23
Description

Samsung Medison acquired and unified NeuroLogica with Boston Imaging under Samsung HME (Healthcare and Medical Equipment) America. NeuroLogica operates as the CT business unit within Samsung's medical imaging portfolio, integrating ultrasound, digital radiography, and CT operations.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-08-28
Description

Samsung India partnered with NeuroLogica to launch a new portfolio of mobile CT scanners in India, including CereTom Elite, OmniTom Elite, OmniTom Elite PCD, and BodyTom 32/64 models. The launch targets expansion into tier-2/3 cities supporting India's digital health transformation.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

One of the largest global medical imaging OEMs with a full portfolio (CT, MR, ultrasound, X-ray, PET). Comparable to NeuroLogica as a CT manufacturer, but operates broadly across imaging modalities and serves hospital customers with much larger installed base and R&D resources.

TypeBroad incumbent
Description

Global imaging OEM with extensive CT portfolio including the NAEOTOM Alpha photon-counting CT. Directly comparable in CT manufacturing and enterprise hospital sales, but offers full imaging modality suite and significantly larger scale.

TypeBroad incumbent
Description

Major diversified imaging OEM offering CT, MR, ultrasound, and image-guided therapy systems. Comparable as a hospital-facing CT and interventional imaging vendor, but with broader modality portfolio and global enterprise footprint.

TypeBroad incumbent
Description

Imaging OEM with CT, MR, ultrasound, and X-ray systems sold to hospitals globally. Comparable as a CT manufacturer targeting enterprise healthcare customers, but with a much broader modality portfolio.

TypeBroad incumbent
Description

Provides medical imaging systems including CT, X-ray, endoscopy, and ultrasound. Comparable as a CT and mobile imaging vendor to hospitals, but operates across broader healthcare segments.

TypeDirect peer
Description

Specializes in mobile C-arm and intraoperative imaging systems for surgery and interventional radiology. Directly comparable to NeuroLogica as a mobile/point-of-care imaging specialist serving hospital OR, ICU, and interventional settings.

TypeDirect peer
Description

Manufactures mobile and portable X-ray imaging systems (DRX-Revolution, etc.) for bedside hospital use. Closely comparable to NeuroLogica's mobile imaging form factor and bedside-care value proposition, though focused on X-ray rather than CT.

TypeBroad incumbent
Description

Through its Medical Imaging division, offers intraoperative imaging and surgical navigation systems used in operating rooms. Comparable to NeuroLogica's surgery and interventional use cases, but part of a much larger medical device portfolio.

TypeEmerging player
Description

Through its Surgical Solutions business, provides intraoperative imaging and navigation for spine and cranial procedures, overlapping with NeuroLogica's interventional/surgery CT use cases. Broader medtech scale, narrower intraoperative focus.

TypeEmerging player
Description

Provides image-guided surgery and neurosurgery planning software and hardware used in OR settings. Comparable to NeuroLogica's neuro and interventional imaging use cases, but positioned more in surgical software/navigation than CT hardware manufacturing.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses3 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

NeuroLogica

Medical Imaging Equipmentneurologica.com

NeuroLogica, a Samsung Medison subsidiary now operating under Samsung HME America, designs and manufactures mobile computed tomography (CT) scanners for hospitals and healthcare facilities, enabling point-of-care imaging in ICUs, operating rooms, neurology, pediatrics, and emergency stroke settings.

What NeuroLogica does

NeuroLogica designs, engineers, manufactures, and markets mobile computed tomography (CT) imaging equipment for healthcare facilities and private practices, with a specific focus on point-of-care imaging that eliminates the need to transport critically ill patients to fixed radiology suites. The company was founded in 2004 and is headquartered in Danvers, Massachusetts, operating as a wholly-owned subsidiary of Samsung Medison (the medical imaging arm of Samsung Electronics); in March 2026, Samsung Medison unified NeuroLogica with Boston Imaging under the corporate identity Samsung HME (Healthcare and Medical Equipment) America, consolidating ultrasound, digital radiography, and CT operations under a single U.S. structure aligned with the global Samsung brand.

The product portfolio is built around four core mobile CT systems: the BodyTom 64 for full-body imaging in adult and pediatric ICUs, interventional radiology, and surgery; the CereTom Elite for compact, rapid brain and neck imaging in neuro and critical care; the OmniTom Elite for advanced neuro, head, and neck imaging; and the OmniTom Elite with PCD, which integrates photon-counting detector technology for ultra-detailed imaging in advanced neuro and research applications. The underlying technology platform emphasizes miniaturization of the CT form factor and, per company materials, incorporates AI-driven imaging capabilities to enhance diagnostic quality at the bedside. The company is also developing next-generation photon-counting detector technology as a roadmap asset.

NeuroLogica generates revenue through one-time capital equipment sales of mobile CT scanners to enterprise healthcare buyers, with pricing handled via quote-based procurement rather than disclosed list prices. Distribution is conducted through Samsung Healthcare's direct enterprise field sales organization globally, with regional expansion supported by partnerships such as the August 2025 Samsung India agreement covering the Indian market. Customer use cases span hospital ICUs and critical care (the primary segment), neurology and neurocritical care, pediatric healthcare, surgery and interventional radiology, and emergency medical services including mobile stroke units. The company maintains 51-100 employees and markets through Samsung Healthcare's integrated digital channels, industry events, and regional sales coverage.

NeuroLogica firmographics

Firmographics
Name
NeuroLogica
Legal name
Samsung Healthcare
Website
https://neurologica.com
Company type
Private
Founded year
2004
Operating status
Operating
Headcount range
51–100 employees
Short description
NeuroLogica, a Samsung Medison subsidiary now operating under Samsung HME America, designs and manufactures mobile computed tomography (CT) scanners for hospitals and healthcare facilities, enabling point-of-care imaging in ICUs, operating rooms, neurology, pediatrics, and emergency stroke settings.
Ownership category
akta.pro rank

NeuroLogica industry classification

Industry
Product category
Medical Imaging Equipment
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451), Medical Equipment and Supplies Manufacturing (3391)
SIC
X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844), Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Computed Tomography (CT) Systems (HLAHABAB)
akta.pro secondary industries
Portable, Mobile & Point-of-Care Imaging Systems (HLAHABAL), Interventional Radiology & Image-Guided Therapy Systems (HLAHABAG)

Keywords

  • Mobile CT scanners
  • Medical imaging equipment
  • Computed tomography systems
  • Point-of-care imaging
  • Radiology hardware

Where NeuroLogica is headquartered

Location

Headquarters

HQ city
Danvers
HQ country
United States
HQ region
North America

Offices1 record

Markets served

NeuroLogica business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Marketing or Sales, Personnel, Operations

Revenue model

  1. Mobile CT Scanner Hardware Sales: Sale of mobile CT scanner systems including BodyTom, CereTom, and OmniTom product lines. Hardware is sold as one-time capital equipment purchases to healthcare facilities.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

NeuroLogica product offering

Product offering

Core offering

NeuroLogica designs, engineers, manufactures and markets mobile computed tomography (CT) scanner systems that bring point-of-care imaging to hospital ICUs, operating rooms, interventional radiology suites, and emergency/mobile stroke settings. Its product line includes the BodyTom 64 (full-body mobile CT), CereTom Elite (compact brain/neck CT), OmniTom Elite (advanced neuro/head/neck CT), and OmniTom Elite with PCD (photon-counting detector CT) for research-grade imaging.

Product overview

NeuroLogica, operating under Samsung HME (Healthcare and Medical Equipment) America, provides a portfolio of mobile computed tomography (CT) scanner solutions designed to transform fixed imaging technologies into point-of-care platforms. The product lineup includes the BodyTom 64 for full-body imaging in ICU and surgical environments, the CereTom Elite for compact brain and neck imaging, the OmniTom Elite for advanced neuro and head/neck applications, and the OmniTom Elite with PCD (photon-counting detector) for ultra-detailed research applications. Together, these mobile CT systems enable bedside diagnostics and reduce patient transfers across hospital settings.

Differentiator

Problem solved

Functional benefit

Brands

  • NeuroLogica: Mobile CT scanner product line featuring BodyTom, CereTom Elite, OmniTom Elite, and OmniTom Elite PCD systems for point-of-care imaging

Products and services

  • BodyTom 64
  • CereTom Elite
  • OmniTom Elite
  • OmniTom Elite with PCD

Companies that use NeuroLogica

Customer profile

Segments5 records

Ideal customer profiles2 records

NeuroLogica technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

NeuroLogica partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • Samsung MedisoncoreStrategic or Co-development Partner · 23 March 2026Samsung Medison acquired and unified NeuroLogica with Boston Imaging under Samsung HME (Healthcare and Medical Equipment) America. NeuroLogica operates as the CT business unit within Samsung's medical imaging portfolio, integrating ultrasound, digital radiography, and CT operations.
  • Samsung IndiacoreStrategic or Co-development Partner · 28 August 2025Samsung India partnered with NeuroLogica to launch a new portfolio of mobile CT scanners in India, including CereTom Elite, OmniTom Elite, OmniTom Elite PCD, and BodyTom 32/64 models. The launch targets expansion into tier-2/3 cities supporting India's digital health transformation.

Scale indicators1 record

Recent moves6 records

Expansion highlights4 records

NeuroLogica competitors and assessment

Company assessment

Broad incumbents

  • GE HealthCare: One of the largest global medical imaging OEMs with a full portfolio (CT, MR, ultrasound, X-ray, PET). Comparable to NeuroLogica as a CT manufacturer, but operates broadly across imaging modalities and serves hospital customers with much larger installed base and R&D resources.
  • Siemens Healthineers: Global imaging OEM with extensive CT portfolio including the NAEOTOM Alpha photon-counting CT. Directly comparable in CT manufacturing and enterprise hospital sales, but offers full imaging modality suite and significantly larger scale.
  • Philips Healthcare: Major diversified imaging OEM offering CT, MR, ultrasound, and image-guided therapy systems. Comparable as a hospital-facing CT and interventional imaging vendor, but with broader modality portfolio and global enterprise footprint.
  • Canon Medical Systems: Imaging OEM with CT, MR, ultrasound, and X-ray systems sold to hospitals globally. Comparable as a CT manufacturer targeting enterprise healthcare customers, but with a much broader modality portfolio.
  • Fujifilm Healthcare: Provides medical imaging systems including CT, X-ray, endoscopy, and ultrasound. Comparable as a CT and mobile imaging vendor to hospitals, but operates across broader healthcare segments.
  • Stryker (Medical Imaging): Through its Medical Imaging division, offers intraoperative imaging and surgical navigation systems used in operating rooms. Comparable to NeuroLogica's surgery and interventional use cases, but part of a much larger medical device portfolio.

Direct peers

  • Ziehm Imaging: Specializes in mobile C-arm and intraoperative imaging systems for surgery and interventional radiology. Directly comparable to NeuroLogica as a mobile/point-of-care imaging specialist serving hospital OR, ICU, and interventional settings.
  • Carestream Health: Manufactures mobile and portable X-ray imaging systems (DRX-Revolution, etc.) for bedside hospital use. Closely comparable to NeuroLogica's mobile imaging form factor and bedside-care value proposition, though focused on X-ray rather than CT.

Emerging players

  • Medtronic (Surgical Imaging): Through its Surgical Solutions business, provides intraoperative imaging and navigation for spine and cranial procedures, overlapping with NeuroLogica's interventional/surgery CT use cases. Broader medtech scale, narrower intraoperative focus.
  • Brainlab: Provides image-guided surgery and neurosurgery planning software and hardware used in OR settings. Comparable to NeuroLogica's neuro and interventional imaging use cases, but positioned more in surgical software/navigation than CT hardware manufacturing.

Market position

Strengths5 records

Weaknesses3 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

NeuroLogica social profiles

Digital presence

NeuroLogica financial estimates

Financial estimate

Revenue estimate

Valuation estimate

NeuroLogica leadership team

Management profile

Number of profiles

Profiles4 records

NeuroLogica funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

NeuroLogica M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NeuroLogica

What does NeuroLogica do?

NeuroLogica designs, engineers, manufactures and markets mobile computed tomography (CT) scanner systems that bring point-of-care imaging to hospital ICUs, operating rooms, interventional radiology suites, and emergency/mobile stroke settings. Its product line includes the BodyTom 64 (full-body mobile CT), CereTom Elite (compact brain/neck CT), OmniTom Elite (advanced neuro/head/neck CT), and OmniTom Elite with PCD (photon-counting detector CT) for research-grade imaging.

Is NeuroLogica a public or private company?

NeuroLogica is a private company. It is classified as corporate owned and is currently operating.

When was NeuroLogica founded?

NeuroLogica was founded in 2004. It employs 51 to 100 people.

Where is NeuroLogica based?

NeuroLogica is headquartered in Danvers, United States, in the North America region.

How does NeuroLogica make money?

One revenue line is on record: mobile CT Scanner Hardware Sales.

Who are NeuroLogica's main competitors?

Broad incumbents on record are GE HealthCare, Siemens Healthineers, Philips Healthcare, Canon Medical Systems, Fujifilm Healthcare and Stryker (Medical Imaging). Direct peers are Ziehm Imaging and Carestream Health. Emerging players are Medtronic (Surgical Imaging) and Brainlab.

Does NeuroLogica have an API?

No public API is recorded for NeuroLogica.

What industry is NeuroLogica in?

NeuroLogica's product category is Medical Imaging Equipment. Its primary akta.pro industry code is HLAHABAB, Computed Tomography (CT) Systems, with a secondary code of HLAHABAL, Portable, Mobile & Point-of-Care Imaging Systems. Its NAICS code is 334510 and its SIC code is 3844.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AuntMinnieSamsung unifies U.S. medical imaging brandsSamsung Medison announced it is consolidating its two U.S. medical imaging businesses—Boston Imaging and NeuroLogica—under a unified brand called Samsung HME (Healthcare and Medical Equipment) America. The rebrand brings together the company's U.S. ultrasound, digital radiography, and CT operations, following recent portfolio activity including AI-enabled R20 and Z20 ultrasound system launches and the acquisition of French AI startup Sonio. Samsung HME America will serve as the global headquarters and manufacturing hub for the CT business, including development of photon counting detector technology.Digital JournalMedical imaging equipment provider receives the ‘Samsung rebrand’Samsung Medison has consolidated its U.S. medical imaging businesses, previously operating as Neurologica and Boston Imaging, under a new unified corporate identity called Samsung HME (Healthcare and Medical Equipment) America. The new structure integrates the company's ultrasound, digital radiography, and computed tomography operations, reflecting Samsung's strategic investment in advancing medical imaging innovation and strengthening its presence in the U.S. healthcare market. Samsung has also recently launched the Samsung R20 and Z20 ultrasound systems and acquired French AI-powered prenatal ultrasound startup Sonio as part of its expanding portfolio.Digital JournalMedical imaging equipment provider receives the ‘Samsung rebrand’Samsung Medison has consolidated its U.S. medical imaging businesses, previously operating as Neurologica and Boston Imaging, under a new unified corporate identity called Samsung HME (Healthcare and Medical Equipment) America. The reorganization brings together the company's ultrasound, digital radiography, and portable CT operations under one integrated structure to strengthen its presence in the U.S. healthcare market. Samsung has also completed the acquisition of French AI-powered prenatal ultrasound startup Sonio, underscoring the company's strategic investment in advancing medical imaging innovation through AI integration.GlobeNewswireNeurological Disorder Diagnostics Research Report 2026 - Global $17.32 Bn Market Trends, Opportunities, and Forecasts to 2031ResearchAndMarkets.com published a global industry report projecting the neurological disorder diagnostics market to grow from USD 10.91 billion in 2025 to USD 17.32 billion by 2031, representing an 8.01% compound annual growth rate. Key market drivers include the rising global prevalence of neurological conditions—with 3.4 billion individuals globally living with a neurological condition according to The Lancet Neurology—and an aging population, while technological innovations in AI-enabled imaging and portable diagnostic devices are identified as key trends reshaping the industry. Market challenges include high capital costs for advanced diagnostic equipment and inadequate reimbursement frameworks in developing regions, which are expected to restrict market penetration and adoption of comprehensive diagnostic solutions.YahooNeurological Disorder Diagnostics Research Report 2026 - Global $17.32 Bn Market Trends, Opportunities, and Forecasts to 2031The global neurological disorder diagnostics market is projected to grow from USD 10.91 billion in 2025 to USD 17.32 billion by 2031, representing a compound annual growth rate of 8.01%. The market growth is primarily driven by an aging global population and rising prevalence of neurodegenerative diseases, though high diagnostic costs and inadequate reimbursement frameworks in developing regions present significant barriers to adoption.Fact.MRFunctional Brain Imaging System MarketThe global functional brain imaging system market is projected to grow from USD 2,180.7 million in 2025 to USD 3,420.6 million by 2035, representing an absolute increase of USD 1,239.9 million at a 4.5% CAGR. Key growth drivers include increasing prevalence of neurological and psychiatric disorders, government healthcare infrastructure initiatives, and technological advancements in imaging resolution and AI integration. The market is segmented by modality (fMRI leading at 49.7% share), application (neurology commanding 44.9%), and end-user (hospitals dominating at 52.7%), with Asia-Pacific identified as the fastest-growing region led by India (6.2% CAGR) and China (5.4% CAGR).Elets BFSISamsung India Unveils Advanced Mobile CT Portfolio to Redefine Patient-Centric ImagingSamsung India, in partnership with its medical imaging subsidiary NeuroLogica, has launched a new portfolio of mobile CT scanners in India, comprising CereTom Elite, OmniTom Elite, OmniTom Elite PCD, and BodyTom 32/64 models. The portfolio combines mobility, AI-driven imaging, and patient-first design to enable bedside diagnostics and reduce patient transfers across hospital settings. The launch aims to expand access to advanced imaging in tier-2/3 cities and support India's digital health transformation.PR NewswireGlobal Computed Tomography (CT) Market Research Report 2024: Level of Care, Cardiology, The New Oncology , Liability, and The Aging Effect are Key Trends Shaping the LandscapeResearchAndMarkets.com announced the addition of a comprehensive global market research report on Computed Tomography (CT) imaging markets, covering 18 countries and 4 regions, with segmentation by application, technology, place of service, and product type. The report examines key industry trends including photon-counting technology, mobile and point-of-care imaging expansion, AI integration, and growth drivers such as cardiology applications, oncology advances, and aging populations. Recent industry developments profiled include GE HealthCare's $30 million AI-powered CT purchase and its planned acquisition of IMACTIS, along with product launches from United Imaging, Philips, and NeuroLogica.Imaging Technology NewsAdvancements in Computed Tomography TechnologyComputed tomography technology has advanced since its 1971 first scan, with the market expected to grow from $8.14 billion in 2023 to $10.95 billion by 2028. Philips launched the CT 3500 AI-powered system, and NeuroLogica's BodyTom 64 received FDA clearance for point-of-care use.PR Newswire1st Annual Mobile Lung Symposium Draws Sellout Audience to Expand Cancer Screenings into the CommunityNeuroLogica and Winnebago Industries' Specialty Vehicles division co-hosted the 1st Annual Mobile Lung Symposium in Minneapolis, MN, drawing a sold-out audience of healthcare professionals to discuss expanding mobile cancer screening into communities. The event featured presentations on lung screening research, mobile CT program establishment, and tours of Winnebago's manufacturing facility in Forest City, Iowa, showcasing the BodyTom Elite portable CT scanner installed in a Winnebago commercial vehicle. The second annual symposium is scheduled for May 2020 in Denver, Colorado.